Welcome

Schiff Glucosamine Buyers Urge OK for $53 Million False Ad Deal

March 3, 2021, 7:25 PM

A $53 million class settlement in a joint-health supplement suit, the largest recovery in a false advertising action involving a retail product, warrants early approval, consumers and Reckitt Benckiser LLC told a California federal court.

The deal gives substantial benefit to class members, according to a motion filed Tuesday in the U.S. District Court for the Northern District of California.

Gordon Noboru Yamagata and others allege Reckitt Benckiser LLC falsely touted its Schiff Move Free Advanced supplements by claiming they offer benefits that they don’t provide.

The nationwide settlement would cover persons who bought the products after May 28, 2015....

To read the full article log in.

Learn more about a Bloomberg Law subscription.